Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient(s)/combinations with the possibility of conclusion at any time within the framework of the so-called Open House procedure
Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
Germany · Potsdam · how to bid here →
Your path to submission
- Deadline: 5 December at 23:58 — 60 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (20 awards, most recently August 2021) — by that rhythm the next award was due around October 2021. The last award went to Bayer Vital GmbH.n = 20
- 24% of this buyer's awards went to companies that had already won here before (59 awards since 2018, spread over 45 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 59 awards since 2018
- The median procedure drew 2 bids (59 procedures with a bid count); 47% ended with a single bidder. Sector: median 2 bids.n = 59
- Across 24 procedures with structured selection criteria, this buyer most often required: Staff qualifications (23 of 24), Trade register enrolment (22 of 24), Security of supply required (1 of 24), Professional liability insurance (1 of 24).n = 24
- Not one of the 59 awards with a known winner country has gone to a foreign company so far. Sector average: 1%.n = 59
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,200 recorded awards) — mostly from Austria, Netherlands, France.
Submission language: DEU.
Typical field: median 19 (from 387 awards).
What the buyer is looking for
The subject of this publication is the conclusion of agreements pursuant to Section 130a(8) SGB V on various active substances/active substance combinations within the framework of a so-called Open House procedure. Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement pursuant to § 130a(8) SGB V on the active substance(s)/combined active substance(s). Interested pharmaceutical companies can, after registration, order documents (participation documents and contract) at: https://www.dtvp.de/Satellite/notice/CXP4Y6M5YH5 download. The e-mail address specified in the Client section for the purpose of unrestricted and complete free access to the order documents does not exist. Information can only be obtained…
Show full description
… via your registration on the "DTVP" allocation platform under the "Communication" tab. Information and answers about other bodies are not binding. A prerequisite for the conclusion of a contract is that the interested pharmaceutical company submits the required procedural documents in full and signed. Any pharmaceutical company that meets the eligibility requirements and documents this by signing the declarations and discount agreement can join the discount agreement. There is no exclusivity. Accession or conclusion of the contract may take place at any time and under the same conditions. Individual contract negotiations are not carried out. The start of the contract can only be one month at a time. The earliest contract start date is 01.02.2025. On this basis, the maximum duration of the contract is 24 months. The contract ends no later than 31.01.2027, regardless of the date of conclusion of the contract. The offer must be submitted at the beginning of the contract by 01.02.2025 at the latest by 23.12.2024; However, no contracts will be concluded by AOK Nordost before 03.01.2025. For a later start of the contract, the deadline for the submission of tenders is the 5th of the previous month. (Example: Contract start 01.03.2025; Deadline for submission of tenders: 05.02.2025). Should AOK Nordost award an exclusive contract for the active substance(s)/combination of active substances within the framework of an open procedure during the contract period, the contractual provisions concluded within the framework of this publication shall apply. This publication does not constitute the award of a public contract within the meaning of the Public Procurement Coordination Directive 2014/24/EU of the European Parliament and of the Council or of public procurement law. Publication in the Supplement to the Official Journal of the European Union shall be carried out in order to ensure the widest possible degree of transparency with regard to the intended conclusion of contracts. In the absence of a publication form, this form of contract notice shall be used. The resulting conceptual requirements, such as the procedural designation of open proceedings, are solely due to the use of this notice form and the publication platform. A further meaning, in particular a submission to public procurement regulations, insofar as they are not obligated for legal reasons, is not associated with this. An announcement of the awarded contracts takes place exclusively under the following link: https://www.aok.de/gp/medicinal products/discount contract background.
What you must prove — eligibility criteria
Interessensbekundung zum Abschluss wirkstoffbezogener Rabattverträge gem. § 130a Abs. 8 SGB V mit der AOK Nordost. Der Nachweis einer Betriebshaftpflichtversicherung muss aktuell gültig sein. Der Handelsregisterauszug muss aktuell sein und nicht älter als 2 Ja… ▸▾
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Hexal AG · Holzkirchen | 21 | 2013–2016 |
| ratiopharm GmbH | 17 | 2013–2016 |
| Aliud Pharma GmbH · Laichingen | 15 | 2013–2016 |
| STADAPHARM GmbH · Bad Vilbel | 13 | 2014–2016 |
| TAD Pharma GmbH · Cuxhaven | 12 | 2013–2016 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.